Elevated Copper Level in Schizophrenia Results in Neurotransmitter and Cognitive Alteration.
Confidence:
0.11
Lucidenic acid A drives PI3K/AKT/BDNF signaling to improve memory impairment in mice and alleviate cellular nerve damage.
Confidence:
0.2
Neuroprotection by canagliflozin in a Huntington's disease model: role of HIF-1ฮฑ and PI3K/AKT signaling.
Confidence:
0.33
Lower baseline serum neuronal-specific enolase levels predict better rate of recovery of functional walking ability in post-acute stroke patients.
Confidence:
0.06
Successful Treatment of Exploding Head Syndrome With Ketamine.
Confidence:
0.18
Axonal growth of cortical neurons does not require paxillin.
Confidence:
0.13
Exercise-Induced Biomarker Modulation in Sarcopenia: From Inflamm-Aging to Muscle Regeneration.
Confidence:
0
Neurotoxicity Assessment of Perfluoroundecanoic Acid (PFUnDA) in Developing Zebrafish (
Confidence:
0.09
Application of Treatment Response Biomarkers from Major Depression to Perinatal Depression.
Confidence:
0
Exercise as a Promising Adjunct Treatment for Methamphetamine Addiction: Advances in Understanding Neuroplasticity and Clinical Applications.
Confidence:
0.08
Negr1 Deficiency Modulates Sex-Specific Neurobehavioral Adaptations to Social Isolation.
Confidence:
0.18
Psychosomatic Disorders, Epigenome, and Gut Microbiota.
Confidence:
0.03
Does Antenatal Lactoferrin Protect Hippocampal Development in Ovine Fetuses with Growth Restriction?
Confidence:
0.19
Curcumin reprograms metabolic pathways and MAPK signaling to exert antidepressant effects.
Confidence:
0.18
Latent classes of mental health disorders and their associations with polymorphisms of 5HTTLPR and BDNF in a Chilean primary care population.
Confidence:
0.02
A standardized combination of
Confidence:
0
Qianzheng powder promotes facial nerve regeneration via BDNF/TrkB/CREB pathway activation.
Confidence:
0.22
Pharmacogenomics of commonly used intravenous anesthetics.
Confidence:
0.09
Effect of Valproate on Serum BDNF and MMP-9 in Pediatric Epilepsy.
Confidence:
0.11